Skip to main content
. 2017 Aug 24;8(47):82835–82841. doi: 10.18632/oncotarget.20463

Table 4. Genotypic model analysis of relationship between rs2274755 and ONFH risk.

Model Genotype Control Case Without adjustment With adjustment AIC BIC
OR (95% CI) p OR (95% CI) P
Codominant G/G 364 (71.8%) 457 (78.1%) 1 0.053 1 0.04* 1508.4 1523.4
G/T 133 (26.2%) 120 (20.5%) 0.72 (0.54-0.95) 0.70 (0.52-0.93)*
T/T 10 (2%) 8 (1.4%) 0.64 (0.25-1.63) 0.65 (0.25-1.68)
Dominant G/G 364 (71.8%) 457 (78.1%) 1 0.016* 1 0.011* 1506.4 1516.4
G/T-T/T 143 (28.2%) 128 (21.9%) 0.71 (0.54-0.94) 0.70 (0.52-0.92)*
Recessive G/G-G/T 497 (98%) 577 (98.6%) 1 0.43 1 0.47 1511.6 1521.6
T/T 10 (2%) 8 (1.4%) 0.69 (0.27-1.76) 0.70 (0.27-1.83)
Overdominant G/G-T/T 374 (73.8%) 465 (79.5%) 1 0.026* 1 0.018* 1507.3 1517.3
G/T 133 (26.2%) 120 (20.5%) 0.73 (0.55-0.96) 0.71 (0.53-0.94)*
Log-additive 0.74 (0.57-0.95) 0.017* 0.72 (0.56-0.94)* 0.013* 1506.5 1516.5

p* ≤ 0.05 indicates statistical significance.

p values were calculated by Wald test by unconditional logistic regression adjusted for age and gender.

AIC = Akaike Information Criterion.

BIC = Bayesian Information Criterion.